Worldwide: Life Sciences, Biotechnology & Nanotechnology

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.

The Life Sciences Boom: H2 2026 Outlook

The 2026 annual Bloom Burton & Co. Healthcare Investor Conference—Canada's premier international forum for healthcare companies and investors—was held in late April in Toronto.

Worldwide Healthcare

BJ

Bennett Jones LLP

Transfer Pricing Rules In Canada

On March 26, 2026, Canada's new transfer pricing rules received royal assent and will have a significant impact on multi-national enterprises (MNEs) in life sciences industries.

BJ

Bennett Jones LLP

Medical Devices Updates: Mandatory Use Of The Regulatory Enrolment Process For Medical Devices And Updated Guidance Documents Related To The Regulatory Enrolment Process

Health Canada released a notice to industry on April 24, 2026, outlining that manufacturers must use the Regulatory Enrolment Process (REP) and Common Electronic Submission Gateway (CESG) for medical device transactions as of April 1, 2026. As we previously reported, manufacturers of medical devices could voluntarily use the REP and CESG for medical device regulatory transactions as of July 2024.

Canada Healthcare

SB

Smart & Biggar

Health Canada Publishes Medical Devices Directorate Quarterly Performance Reports For Q2 And Q3 Of 2025/2026

In January and February 2026, Health Canada released the Quarterly Report for Q2 2025-2026 (July through September 2025) and for Q3 2025-2026 (October through December 2025).

Canada Healthcare

SB

Smart & Biggar

Life Sciences Outlook 2026

Canada Healthcare

BJ

Bennett Jones LLP

BCF Acts As Counsel To Celystra Pharma As Part Of An Equity Investment

Canada Healthcare

BB

BCF Business Law

Santé Canada sollicite des commentaires sur la mise en œuvre progressive de la liste incorporée par renvoi dans le cadre de l’arrêté ministériel relatif à la confiance

Canada Healthcare

SB

Smart & Biggar

Ontario Superior Court Limits Damages Claims In Certifying Personal Injury Medical Device Class Action

Canada Litigation

BJ

Bennett Jones LLP

Northern Advantage: Canada's Federal Court As A Venue For Pharmaceutical Patent Litigation

BJ

Bennett Jones LLP

Mise à jour sur les instruments médicaux : utilisation obligatoire du processus d’inscription réglementaire pour les instruments médicaux et mise à jour des lignes directrices relatives à ce processus

Canada Healthcare

SB

Smart & Biggar

Deference Prevails: A Public Drug Funding Decision In Québec Is Upheld On Reasonableness Review

Canada Healthcare

TL

Torys LLP

Class Action Pursued Over Infection Risks Linked To Endoscope Devices

Canada Consumer

SL

Siskinds LLP

Tout ce qu'il faut savoir sur les lignes directrices mises à jour et les exemples 2026 de l'OPIC concernant l'objet brevetable

SB

Smart & Biggar

Canada Announces New Pharmaceutical And Life Sciences Sector Task Force

Canada Healthcare

SB

Smart & Biggar

Digging Into Change: Ontario Proposes Updates To Archaeological Assessment Standards

Canada Real Estate

DH

Davies Howe

How The Canadian Foreign Accrual Property Income (FAPI) Regime Works—and Why It Matters To Foreign Corporations, Foreign Trusts

RS

Rotfleisch & Samulovitch P.C.

A Practical Guide For Business Owners Expanding Or Relocating To Ontario, Canada (Video)

Canada Commercial

LL

Lerners LLP

QSBC Shares And The 24 Month Holding Period Requirement

L

Linmac

New Principles For AI Use In Ontario

Canada Technology

MT

Miller Thomson LLP

PMPRB Consults On Proposed Practice Directions For PMPRB Hearings

The  Patented Medicine Prices Review Board (PMPRB) holds public hearings on two types of matters...

SB

Smart & Biggar

Le CEPMB lance une consultation concernant le projet de directives relatives à la pratique pour ses audiences

pour déterminer si un titulaire de droits a omis de soumettre les renseignements exigés conformément à la Loi sur les brevets et au Règlementsur les médicaments brevetés.

Canada Technology

SB

Smart & Biggar

Changing Life Sciences' Patent Landscape: It's Time To Talk About Efficient Licensing

Life sciences has transformed and the patent landscape is transforming with it. Platform technologies, from connectivity standards embedded in smart medical devices...

GW

Gowling WLG

L'intelligence artificielle prescrira-t-elle bientôt des médicaments au Canada? Les leçons du programme novateur de l'Utah

Les organismes réglementaires canadiens pourraient bientôt devoir se prononcer sur le rôle de l'intelligence artificielle (« IA ») autonome dans la prestation des soins de santé.

Canada Healthcare

FF

Fasken (French)

Updated Guidance From CIPO On Patentable Subject-Matter

ML

McMillan LLP

Torys On Defence: The Role Of Life Sciences In Canada's Defence Capabilities

Canada Healthcare

TL

Torys LLP

Could Artificial Intelligence Soon Prescribe Drugs In Canada? Lessons From Utah's Landmark Program

Canada Healthcare

F

Fasken

PMPRB Launches Consultation On Proposed Practice Directions For Hearings

Canada Healthcare

MT

McCarthy Tétrault LLP

Federal Court Denies Class Action Certification In Generic Drug Price Fixing Case

Canada Healthcare

SB

Smart & Biggar

La Cour fédérale rejette une requête en autorisation de recours collectif relative à la fixation des prix de médicaments génériques

Canada Healthcare

SB

Smart & Biggar

Update On Proposed Ministerial Reliance Order

Canada Healthcare

SB

Smart & Biggar

Mise à jour sur la proposition d'arrêté ministériel relatif à la confiance

Canada Healthcare

SB

Smart & Biggar

L'Agence des médicaments du Canada annonce une consultation sur le processus d'examen simplifié et de nouvelles procédures en ce qui concerne les reconsidérations et les nouvelles demandes d'examen

Canada Healthcare

SB

Smart & Biggar

Canada's Drug Agency Announces Consultation On Streamlined Review Process And New Reconsideration/resubmission Procedures

Canada Healthcare

SB

Smart & Biggar

Update On Proposed Ministerial Reliance Order

As we reported last month, the Minister of Health launched a consultation on a proposed Ministerial Reliance Order that would permit Health Canada to complete the examination of certain parts...

Canada Healthcare

SB

Smart & Biggar

Mise à jour sur la proposition d'arrêté ministériel relatif à la confiance

Comme nous l'avons indiqué le mois dernier, la ministre de la Santé a lancé une consultation sur une proposition d'arrêté ministériel relatif à la confiance qui permettrait...

Canada Healthcare

SB

Smart & Biggar

L'Agence des médicaments du Canada annonce une consultation sur le processus d'examen simplifié et de nouvelles procédures en ce qui concerne les reconsidérations et les nouvelles demandes d'examen

Le 29 janvier 2026, l'Agence des médicaments du Canada (l'« AMC ») a publié des Améliorations au processus d'examen en vue du remboursement d'un médicament...

Canada Healthcare

SB

Smart & Biggar

Canada's Drug Agency Announces Consultation On Streamlined Review Process And New Reconsideration/resubmission Procedures

On January 29, 2026, Canada's Drug Agency (CDA) published Improvements to the Drug Reimbursement Review Process, which includes a section for consultation on proposed changes to the reimbursement review process.

Canada Healthcare

SB

Smart & Biggar

New PMPRB Chairperson And PMPRB Releases January 2026 NEWSletter

Canada Healthcare

SB

Smart & Biggar

Les 10 articles incontournables de la Mise à jour en PI Rx en 2025

Voici les articles les plus lus de la rubrique Mise à jour en PI Rx en 2025...

Canada Healthcare

SB

Smart & Biggar

Top Ten Rx IP Update Reads Of 2025

Below are Rx IP Update's most-read articles of 2025...

SB

Smart & Biggar

Top Ten Rx IP Update Reads Of 2025

Below are Rx IP Update's most-read articles of 2025...

SB

Smart & Biggar

Canada Accelerates Regulatory Modernization

Health Canada's 2025 Red Tape Review has sparked significant regulatory reforms aimed at streamlining drug and medical device approvals through international harmonization. New draft guidance and proposed legislative changes promise to reduce clinical trial requirements for biosimilars, enable faster approvals through foreign reliance pathways, and eliminate redundant licensing requirements for medical device importers.

Canada Healthcare

BJ

Bennett Jones LLP

Les faits saillants de 2025 au Canada en matière de PI en sciences de la vie et de droit réglementaire

Canada Healthcare

SB

Smart & Biggar

2025 Highlights In Canadian Life Sciences IP And Regulatory Law

Canada Healthcare

SB

Smart & Biggar

Santé Canada lance une consultation sur deux documents d'ébauche de lignes directrices sur les conditions pour les médicaments à usage humain et vétérinaire ainsi que les présentations de drogues basées sur des preuves prometteuses d'efficacité clinique

Canada Healthcare

SB

Smart & Biggar

Proposal For Modernizing Clinical Trial Framework Aims To Improve Access To New And Innovative Therapies In Canada

Canada Healthcare

SB

Smart & Biggar

Une proposition de modernisation du cadre des essais cliniques pour favoriser l'accès à de nouvelles thérapies innovantes au Canada

Canada Healthcare

SB

Smart & Biggar

Cancer-linked Drug And Product Lawsuits: Legal Pathways For Affected Patients

Canada Healthcare

SL

Siskinds LLP

Naming Natural Health Products: Branding In A Grey Zone

Canada Healthcare

ML

McMillan LLP

Proposed New Requirements For Lithium-Ion Batteries In Consumer Products

Canada Consumer

GR

Gardiner Roberts LLP

How Is AI Transforming The Life Sciences Industry?

Canada Technology

TL

Torys LLP

What You Should Know About The Freestyle Libre 3 Recall

Worldwide Litigation

GP

Gluckstein Lawyers

VC Investment In Canada For Life Sciences Companies

Canada Healthcare

MT

McCarthy Tétrault LLP

Mise à jour sur le CEPMB : Entrée en vigueur des Lignes directrices pour le personnel du CEPMB le 1er janvier 2026 et Rapport annuel 2024

Canada Healthcare

SB

Smart & Biggar

PMPRB Update: Guidelines For PMPRB Staff Come Into Effect January 1, 2026; 2024 Annual Report

Canada Healthcare

SB

Smart & Biggar

Medical Devices Updates: Phase II Consultation On Medical Devices Regulations Amendments, Medical Device Licences Guidance And IMDRF Table Of Contents Guidance

Canada Healthcare

SB

Smart & Biggar

Mise à jour sur les instruments médicaux : Phase II de la consultation sur les modifications au Règlement sur les instruments médicaux, et lignes directrices sur l'homologation d'instruments médicaux et sur la table des matières de l'IMDRF

Canada Healthcare

SB

Smart & Biggar

See more

Latest Videos

See more

Lois canadiennes, américaines, britanniques et européennes entourant l'Internet des objets (Video)

BL

Borden Ladner Gervais LLP

The Legal Steps To Startups: Health & Life Science (Video)

PM

Parlee McLaws

Navigating (and Challenging) A Changing Life Sciences Regulatory Environment (Video)

TL

Torys LLP

Canada's Healthcare Industry After COVID-19: Legal, Medical And Business Perspectives (Video)

SE

Stikeman Elliott LLP

Generic Damages In Life Sciences Patent Litigation: Strategic Considerations (Video Content)

GW

Gowling WLG

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More